nodes	percent_of_prediction	percent_of_DWPC	metapath
Propantheline—Nervousness—Bromocriptine—type 2 diabetes mellitus	0.00297	0.00414	CcSEcCtD
Propantheline—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00295	0.00412	CcSEcCtD
Propantheline—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00295	0.00412	CcSEcCtD
Propantheline—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00291	0.00407	CcSEcCtD
Propantheline—Constipation—Rosiglitazone—type 2 diabetes mellitus	0.00289	0.00404	CcSEcCtD
Propantheline—Vision blurred—Bromocriptine—type 2 diabetes mellitus	0.00288	0.00402	CcSEcCtD
Propantheline—Abdominal distension—Irbesartan—type 2 diabetes mellitus	0.00286	0.00399	CcSEcCtD
Propantheline—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00284	0.00397	CcSEcCtD
Propantheline—Dysphagia—Irbesartan—type 2 diabetes mellitus	0.00284	0.00396	CcSEcCtD
Propantheline—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00284	0.00396	CcSEcCtD
Propantheline—Anaphylactic shock—Pioglitazone—type 2 diabetes mellitus	0.00284	0.00396	CcSEcCtD
Propantheline—Dry mouth—Glimepiride—type 2 diabetes mellitus	0.00282	0.00393	CcSEcCtD
Propantheline—Rash—Chlorpropamide—type 2 diabetes mellitus	0.00281	0.00393	CcSEcCtD
Propantheline—Rash—Tolazamide—type 2 diabetes mellitus	0.00281	0.00393	CcSEcCtD
Propantheline—Dry mouth—Sitagliptin—type 2 diabetes mellitus	0.00281	0.00392	CcSEcCtD
Propantheline—Headache—Tolazamide—type 2 diabetes mellitus	0.0028	0.0039	CcSEcCtD
Propantheline—Headache—Chlorpropamide—type 2 diabetes mellitus	0.0028	0.0039	CcSEcCtD
Propantheline—Confusional state—Glimepiride—type 2 diabetes mellitus	0.00279	0.00389	CcSEcCtD
Propantheline—Rash—Linagliptin—type 2 diabetes mellitus	0.00278	0.00389	CcSEcCtD
Propantheline—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.00278	0.00388	CcSEcCtD
Propantheline—Headache—Linagliptin—type 2 diabetes mellitus	0.00277	0.00386	CcSEcCtD
Propantheline—Anaphylactic shock—Glimepiride—type 2 diabetes mellitus	0.00276	0.00385	CcSEcCtD
Propantheline—Anaphylactic shock—Sitagliptin—type 2 diabetes mellitus	0.00275	0.00384	CcSEcCtD
Propantheline—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00273	0.00381	CcSEcCtD
Propantheline—Vomiting—Acarbose—type 2 diabetes mellitus	0.00273	0.0038	CcSEcCtD
Propantheline—Rash—Acarbose—type 2 diabetes mellitus	0.0027	0.00377	CcSEcCtD
Propantheline—Dermatitis—Acarbose—type 2 diabetes mellitus	0.0027	0.00377	CcSEcCtD
Propantheline—Tachycardia—Glimepiride—type 2 diabetes mellitus	0.0027	0.00376	CcSEcCtD
Propantheline—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00269	0.00375	CcSEcCtD
Propantheline—Drowsiness—Metformin—type 2 diabetes mellitus	0.00268	0.00374	CcSEcCtD
Propantheline—Insomnia—Glipizide—type 2 diabetes mellitus	0.00268	0.00374	CcSEcCtD
Propantheline—Flushing—Gliclazide—type 2 diabetes mellitus	0.00267	0.00373	CcSEcCtD
Propantheline—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00265	0.0037	CcSEcCtD
Propantheline—Nausea—Tolazamide—type 2 diabetes mellitus	0.00265	0.0037	CcSEcCtD
Propantheline—Hypersensitivity—Repaglinide—type 2 diabetes mellitus	0.00264	0.00368	CcSEcCtD
Propantheline—Somnolence—Glipizide—type 2 diabetes mellitus	0.00263	0.00367	CcSEcCtD
Propantheline—Vision blurred—Glyburide—type 2 diabetes mellitus	0.00263	0.00367	CcSEcCtD
Propantheline—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00263	0.00367	CcSEcCtD
Propantheline—Rash—Nateglinide—type 2 diabetes mellitus	0.00261	0.00364	CcSEcCtD
Propantheline—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.0026	0.00363	CcSEcCtD
Propantheline—Insomnia—Pioglitazone—type 2 diabetes mellitus	0.00257	0.00358	CcSEcCtD
Propantheline—Nausea—Acarbose—type 2 diabetes mellitus	0.00255	0.00355	CcSEcCtD
Propantheline—Dry mouth—Bromocriptine—type 2 diabetes mellitus	0.00254	0.00355	CcSEcCtD
Propantheline—Constipation—Glipizide—type 2 diabetes mellitus	0.00253	0.00353	CcSEcCtD
Propantheline—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.00251	0.00351	CcSEcCtD
Propantheline—Insomnia—Glimepiride—type 2 diabetes mellitus	0.0025	0.00349	CcSEcCtD
Propantheline—Insomnia—Sitagliptin—type 2 diabetes mellitus	0.00249	0.00348	CcSEcCtD
Propantheline—Erectile dysfunction—Losartan—type 2 diabetes mellitus	0.00246	0.00344	CcSEcCtD
Propantheline—Tension—Gliclazide—type 2 diabetes mellitus	0.00246	0.00343	CcSEcCtD
Propantheline—Somnolence—Glimepiride—type 2 diabetes mellitus	0.00246	0.00343	CcSEcCtD
Propantheline—Nausea—Nateglinide—type 2 diabetes mellitus	0.00246	0.00343	CcSEcCtD
Propantheline—Somnolence—Sitagliptin—type 2 diabetes mellitus	0.00245	0.00342	CcSEcCtD
Propantheline—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.00244	0.0034	CcSEcCtD
Propantheline—Nervousness—Gliclazide—type 2 diabetes mellitus	0.00243	0.0034	CcSEcCtD
Propantheline—Tachycardia—Bromocriptine—type 2 diabetes mellitus	0.00243	0.00339	CcSEcCtD
Propantheline—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.00243	0.00339	CcSEcCtD
Propantheline—Constipation—Sitagliptin—type 2 diabetes mellitus	0.00236	0.00329	CcSEcCtD
Propantheline—Urticaria—Glipizide—type 2 diabetes mellitus	0.00235	0.00328	CcSEcCtD
Propantheline—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00234	0.00326	CcSEcCtD
Propantheline—Confusional state—Glyburide—type 2 diabetes mellitus	0.0023	0.00321	CcSEcCtD
Propantheline—Dysphagia—Ramipril—type 2 diabetes mellitus	0.00229	0.0032	CcSEcCtD
Propantheline—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.00228	0.00318	CcSEcCtD
Propantheline—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00228	0.00317	CcSEcCtD
Propantheline—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.00227	0.00317	CcSEcCtD
Propantheline—Rash—Repaglinide—type 2 diabetes mellitus	0.00226	0.00315	CcSEcCtD
Propantheline—Insomnia—Bromocriptine—type 2 diabetes mellitus	0.00225	0.00315	CcSEcCtD
Propantheline—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00225	0.00315	CcSEcCtD
Propantheline—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00225	0.00314	CcSEcCtD
Propantheline—Headache—Repaglinide—type 2 diabetes mellitus	0.00224	0.00313	CcSEcCtD
Propantheline—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00224	0.00312	CcSEcCtD
Propantheline—Flushing—Metformin—type 2 diabetes mellitus	0.00224	0.00312	CcSEcCtD
Propantheline—Somnolence—Bromocriptine—type 2 diabetes mellitus	0.00222	0.00309	CcSEcCtD
Propantheline—Palpitations—Gliclazide—type 2 diabetes mellitus	0.00222	0.00309	CcSEcCtD
Propantheline—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00219	0.00306	CcSEcCtD
Propantheline—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00219	0.00305	CcSEcCtD
Propantheline—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00218	0.00304	CcSEcCtD
Propantheline—Vision blurred—Valsartan—type 2 diabetes mellitus	0.00217	0.00303	CcSEcCtD
Propantheline—Vision blurred—Orlistat—type 2 diabetes mellitus	0.00214	0.00299	CcSEcCtD
Propantheline—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00213	0.00298	CcSEcCtD
Propantheline—Constipation—Bromocriptine—type 2 diabetes mellitus	0.00213	0.00297	CcSEcCtD
Propantheline—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00213	0.00297	CcSEcCtD
Propantheline—Nausea—Repaglinide—type 2 diabetes mellitus	0.00213	0.00297	CcSEcCtD
Propantheline—Asthenia—Glipizide—type 2 diabetes mellitus	0.00212	0.00296	CcSEcCtD
Propantheline—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00212	0.00296	CcSEcCtD
Propantheline—Erectile dysfunction—Ramipril—type 2 diabetes mellitus	0.00211	0.00295	CcSEcCtD
Propantheline—Flushing—Irbesartan—type 2 diabetes mellitus	0.00211	0.00294	CcSEcCtD
Propantheline—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00209	0.00292	CcSEcCtD
Propantheline—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.00209	0.00291	CcSEcCtD
Propantheline—Confusional state—Gliclazide—type 2 diabetes mellitus	0.00206	0.00288	CcSEcCtD
Propantheline—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.00205	0.00287	CcSEcCtD
Propantheline—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00204	0.00284	CcSEcCtD
Propantheline—Palpitations—Valsartan—type 2 diabetes mellitus	0.00204	0.00284	CcSEcCtD
Propantheline—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00203	0.00284	CcSEcCtD
Propantheline—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.00203	0.00283	CcSEcCtD
Propantheline—Palpitations—Orlistat—type 2 diabetes mellitus	0.00201	0.00281	CcSEcCtD
Propantheline—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00201	0.0028	CcSEcCtD
Propantheline—Tachycardia—Gliclazide—type 2 diabetes mellitus	0.002	0.00279	CcSEcCtD
Propantheline—Flushing—Losartan—type 2 diabetes mellitus	0.00199	0.00277	CcSEcCtD
Propantheline—Asthenia—Glimepiride—type 2 diabetes mellitus	0.00198	0.00277	CcSEcCtD
Propantheline—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00198	0.00276	CcSEcCtD
Propantheline—Vision blurred—Metformin—type 2 diabetes mellitus	0.00198	0.00276	CcSEcCtD
Propantheline—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.00198	0.00276	CcSEcCtD
Propantheline—Dizziness—Glipizide—type 2 diabetes mellitus	0.00196	0.00273	CcSEcCtD
Propantheline—Tension—Irbesartan—type 2 diabetes mellitus	0.00194	0.00271	CcSEcCtD
Propantheline—Nervousness—Irbesartan—type 2 diabetes mellitus	0.00192	0.00268	CcSEcCtD
Propantheline—Dry mouth—Valsartan—type 2 diabetes mellitus	0.00192	0.00268	CcSEcCtD
Propantheline—Dry mouth—Orlistat—type 2 diabetes mellitus	0.00189	0.00264	CcSEcCtD
Propantheline—Vomiting—Glipizide—type 2 diabetes mellitus	0.00188	0.00263	CcSEcCtD
Propantheline—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.00188	0.00262	CcSEcCtD
Propantheline—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.00188	0.00262	CcSEcCtD
Propantheline—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.00188	0.00262	CcSEcCtD
Propantheline—Rash—Glipizide—type 2 diabetes mellitus	0.00187	0.0026	CcSEcCtD
Propantheline—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00187	0.0026	CcSEcCtD
Propantheline—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00186	0.0026	CcSEcCtD
Propantheline—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.00186	0.00259	CcSEcCtD
Propantheline—Headache—Glipizide—type 2 diabetes mellitus	0.00185	0.00259	CcSEcCtD
Propantheline—Palpitations—Metformin—type 2 diabetes mellitus	0.00185	0.00259	CcSEcCtD
Propantheline—Insomnia—Gliclazide—type 2 diabetes mellitus	0.00185	0.00258	CcSEcCtD
Propantheline—Tension—Losartan—type 2 diabetes mellitus	0.00183	0.00255	CcSEcCtD
Propantheline—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00183	0.00255	CcSEcCtD
Propantheline—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00182	0.00254	CcSEcCtD
Propantheline—Somnolence—Gliclazide—type 2 diabetes mellitus	0.00182	0.00254	CcSEcCtD
Propantheline—Urticaria—Glyburide—type 2 diabetes mellitus	0.00181	0.00253	CcSEcCtD
Propantheline—Nervousness—Losartan—type 2 diabetes mellitus	0.00181	0.00252	CcSEcCtD
Propantheline—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00179	0.0025	CcSEcCtD
Propantheline—Headache—Pioglitazone—type 2 diabetes mellitus	0.00178	0.00248	CcSEcCtD
Propantheline—Nausea—Glipizide—type 2 diabetes mellitus	0.00176	0.00245	CcSEcCtD
Propantheline—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00176	0.00245	CcSEcCtD
Propantheline—Vision blurred—Losartan—type 2 diabetes mellitus	0.00176	0.00245	CcSEcCtD
Propantheline—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.00175	0.00244	CcSEcCtD
Propantheline—Constipation—Gliclazide—type 2 diabetes mellitus	0.00175	0.00244	CcSEcCtD
Propantheline—Rash—Glimepiride—type 2 diabetes mellitus	0.00174	0.00243	CcSEcCtD
Propantheline—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00174	0.00243	CcSEcCtD
Propantheline—Rash—Sitagliptin—type 2 diabetes mellitus	0.00174	0.00242	CcSEcCtD
Propantheline—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00173	0.00242	CcSEcCtD
Propantheline—Headache—Glimepiride—type 2 diabetes mellitus	0.00173	0.00241	CcSEcCtD
Propantheline—Headache—Sitagliptin—type 2 diabetes mellitus	0.00173	0.00241	CcSEcCtD
Propantheline—Flushing—Ramipril—type 2 diabetes mellitus	0.0017	0.00238	CcSEcCtD
Propantheline—Insomnia—Valsartan—type 2 diabetes mellitus	0.0017	0.00237	CcSEcCtD
Propantheline—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00169	0.00235	CcSEcCtD
Propantheline—Insomnia—Orlistat—type 2 diabetes mellitus	0.00168	0.00234	CcSEcCtD
Propantheline—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.00168	0.00234	CcSEcCtD
Propantheline—Somnolence—Valsartan—type 2 diabetes mellitus	0.00167	0.00233	CcSEcCtD
Propantheline—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00165	0.0023	CcSEcCtD
Propantheline—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00165	0.0023	CcSEcCtD
Propantheline—Palpitations—Losartan—type 2 diabetes mellitus	0.00165	0.0023	CcSEcCtD
Propantheline—Nausea—Glimepiride—type 2 diabetes mellitus	0.00164	0.00229	CcSEcCtD
Propantheline—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00164	0.00228	CcSEcCtD
Propantheline—Asthenia—Glyburide—type 2 diabetes mellitus	0.00163	0.00228	CcSEcCtD
Propantheline—Urticaria—Gliclazide—type 2 diabetes mellitus	0.00163	0.00227	CcSEcCtD
Propantheline—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.00162	0.00225	CcSEcCtD
Propantheline—Constipation—Valsartan—type 2 diabetes mellitus	0.00161	0.00224	CcSEcCtD
Propantheline—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00158	0.00221	CcSEcCtD
Propantheline—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.00158	0.0022	CcSEcCtD
Propantheline—Rash—Bromocriptine—type 2 diabetes mellitus	0.00157	0.00219	CcSEcCtD
Propantheline—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00157	0.00219	CcSEcCtD
Propantheline—Tension—Ramipril—type 2 diabetes mellitus	0.00157	0.00219	CcSEcCtD
Propantheline—Headache—Bromocriptine—type 2 diabetes mellitus	0.00156	0.00218	CcSEcCtD
Propantheline—Nervousness—Ramipril—type 2 diabetes mellitus	0.00155	0.00216	CcSEcCtD
Propantheline—Dry mouth—Losartan—type 2 diabetes mellitus	0.00155	0.00216	CcSEcCtD
Propantheline—Confusional state—Losartan—type 2 diabetes mellitus	0.00153	0.00214	CcSEcCtD
Propantheline—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.00153	0.00214	CcSEcCtD
Propantheline—Somnolence—Metformin—type 2 diabetes mellitus	0.00152	0.00212	CcSEcCtD
Propantheline—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00152	0.00212	CcSEcCtD
Propantheline—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00151	0.0021	CcSEcCtD
Propantheline—Urticaria—Valsartan—type 2 diabetes mellitus	0.00149	0.00208	CcSEcCtD
Propantheline—Tachycardia—Losartan—type 2 diabetes mellitus	0.00148	0.00207	CcSEcCtD
Propantheline—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00148	0.00207	CcSEcCtD
Propantheline—Urticaria—Orlistat—type 2 diabetes mellitus	0.00148	0.00206	CcSEcCtD
Propantheline—Asthenia—Gliclazide—type 2 diabetes mellitus	0.00147	0.00205	CcSEcCtD
Propantheline—Constipation—Metformin—type 2 diabetes mellitus	0.00146	0.00204	CcSEcCtD
Propantheline—Vomiting—Glyburide—type 2 diabetes mellitus	0.00145	0.00202	CcSEcCtD
Propantheline—Rash—Glyburide—type 2 diabetes mellitus	0.00144	0.002	CcSEcCtD
Propantheline—Somnolence—Irbesartan—type 2 diabetes mellitus	0.00144	0.002	CcSEcCtD
Propantheline—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00144	0.002	CcSEcCtD
Propantheline—Headache—Glyburide—type 2 diabetes mellitus	0.00143	0.00199	CcSEcCtD
Propantheline—Palpitations—Ramipril—type 2 diabetes mellitus	0.00141	0.00197	CcSEcCtD
Propantheline—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.00141	0.00197	CcSEcCtD
Propantheline—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.00138	0.00193	CcSEcCtD
Propantheline—Constipation—Irbesartan—type 2 diabetes mellitus	0.00138	0.00193	CcSEcCtD
Propantheline—Insomnia—Losartan—type 2 diabetes mellitus	0.00138	0.00192	CcSEcCtD
Propantheline—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.00137	0.00191	CcSEcCtD
Propantheline—Urticaria—Metformin—type 2 diabetes mellitus	0.00136	0.0019	CcSEcCtD
Propantheline—Nausea—Glyburide—type 2 diabetes mellitus	0.00135	0.00189	CcSEcCtD
Propantheline—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00135	0.00189	CcSEcCtD
Propantheline—Somnolence—Losartan—type 2 diabetes mellitus	0.00135	0.00189	CcSEcCtD
Propantheline—Asthenia—Valsartan—type 2 diabetes mellitus	0.00135	0.00188	CcSEcCtD
Propantheline—Asthenia—Orlistat—type 2 diabetes mellitus	0.00133	0.00186	CcSEcCtD
Propantheline—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.00133	0.00186	CcSEcCtD
Propantheline—Dry mouth—Ramipril—type 2 diabetes mellitus	0.00133	0.00186	CcSEcCtD
Propantheline—Confusional state—Ramipril—type 2 diabetes mellitus	0.00131	0.00183	CcSEcCtD
Propantheline—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.0013	0.00182	CcSEcCtD
Propantheline—Vomiting—Gliclazide—type 2 diabetes mellitus	0.0013	0.00181	CcSEcCtD
Propantheline—Constipation—Losartan—type 2 diabetes mellitus	0.0013	0.00181	CcSEcCtD
Propantheline—Rash—Gliclazide—type 2 diabetes mellitus	0.00129	0.0018	CcSEcCtD
Propantheline—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00129	0.0018	CcSEcCtD
Propantheline—Urticaria—Irbesartan—type 2 diabetes mellitus	0.00128	0.00179	CcSEcCtD
Propantheline—Headache—Gliclazide—type 2 diabetes mellitus	0.00128	0.00179	CcSEcCtD
Propantheline—Tachycardia—Ramipril—type 2 diabetes mellitus	0.00127	0.00178	CcSEcCtD
Propantheline—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.00125	0.00175	CcSEcCtD
Propantheline—Dizziness—Valsartan—type 2 diabetes mellitus	0.00124	0.00173	CcSEcCtD
Propantheline—Dizziness—Orlistat—type 2 diabetes mellitus	0.00123	0.00171	CcSEcCtD
Propantheline—Asthenia—Metformin—type 2 diabetes mellitus	0.00123	0.00171	CcSEcCtD
Propantheline—Nausea—Gliclazide—type 2 diabetes mellitus	0.00122	0.0017	CcSEcCtD
Propantheline—Urticaria—Losartan—type 2 diabetes mellitus	0.00121	0.00169	CcSEcCtD
Propantheline—Vomiting—Valsartan—type 2 diabetes mellitus	0.0012	0.00167	CcSEcCtD
Propantheline—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00119	0.00166	CcSEcCtD
Propantheline—Rash—Valsartan—type 2 diabetes mellitus	0.00119	0.00165	CcSEcCtD
Propantheline—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00118	0.00165	CcSEcCtD
Propantheline—Vomiting—Orlistat—type 2 diabetes mellitus	0.00118	0.00165	CcSEcCtD
Propantheline—Insomnia—Ramipril—type 2 diabetes mellitus	0.00118	0.00164	CcSEcCtD
Propantheline—Headache—Valsartan—type 2 diabetes mellitus	0.00118	0.00164	CcSEcCtD
Propantheline—Rash—Orlistat—type 2 diabetes mellitus	0.00117	0.00163	CcSEcCtD
Propantheline—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00117	0.00163	CcSEcCtD
Propantheline—Headache—Orlistat—type 2 diabetes mellitus	0.00116	0.00162	CcSEcCtD
Propantheline—Asthenia—Irbesartan—type 2 diabetes mellitus	0.00116	0.00162	CcSEcCtD
Propantheline—Somnolence—Ramipril—type 2 diabetes mellitus	0.00116	0.00162	CcSEcCtD
Propantheline—Dizziness—Metformin—type 2 diabetes mellitus	0.00113	0.00158	CcSEcCtD
Propantheline—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00112	0.00156	CcSEcCtD
Propantheline—Nausea—Valsartan—type 2 diabetes mellitus	0.00112	0.00156	CcSEcCtD
Propantheline—Constipation—Ramipril—type 2 diabetes mellitus	0.00111	0.00156	CcSEcCtD
Propantheline—Nausea—Orlistat—type 2 diabetes mellitus	0.0011	0.00154	CcSEcCtD
Propantheline—Asthenia—Losartan—type 2 diabetes mellitus	0.00109	0.00152	CcSEcCtD
Propantheline—Vomiting—Metformin—type 2 diabetes mellitus	0.00109	0.00152	CcSEcCtD
Propantheline—Rash—Metformin—type 2 diabetes mellitus	0.00108	0.00151	CcSEcCtD
Propantheline—Dermatitis—Metformin—type 2 diabetes mellitus	0.00108	0.0015	CcSEcCtD
Propantheline—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.00107	0.0015	CcSEcCtD
Propantheline—Headache—Metformin—type 2 diabetes mellitus	0.00107	0.0015	CcSEcCtD
Propantheline—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00107	0.00149	CcSEcCtD
Propantheline—Urticaria—Ramipril—type 2 diabetes mellitus	0.00104	0.00144	CcSEcCtD
Propantheline—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00103	0.00143	CcSEcCtD
Propantheline—Rash—Irbesartan—type 2 diabetes mellitus	0.00102	0.00142	CcSEcCtD
Propantheline—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00102	0.00142	CcSEcCtD
Propantheline—Nausea—Metformin—type 2 diabetes mellitus	0.00102	0.00142	CcSEcCtD
Propantheline—Headache—Irbesartan—type 2 diabetes mellitus	0.00101	0.00141	CcSEcCtD
Propantheline—Dizziness—Losartan—type 2 diabetes mellitus	0.00101	0.0014	CcSEcCtD
Propantheline—Vomiting—Losartan—type 2 diabetes mellitus	0.000967	0.00135	CcSEcCtD
Propantheline—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.00096	0.00134	CcSEcCtD
Propantheline—Nausea—Irbesartan—type 2 diabetes mellitus	0.00096	0.00134	CcSEcCtD
Propantheline—Rash—Losartan—type 2 diabetes mellitus	0.000959	0.00134	CcSEcCtD
Propantheline—Dermatitis—Losartan—type 2 diabetes mellitus	0.000958	0.00134	CcSEcCtD
Propantheline—Headache—Losartan—type 2 diabetes mellitus	0.000952	0.00133	CcSEcCtD
Propantheline—Asthenia—Ramipril—type 2 diabetes mellitus	0.000935	0.0013	CcSEcCtD
Propantheline—Nausea—Losartan—type 2 diabetes mellitus	0.000903	0.00126	CcSEcCtD
Propantheline—Dizziness—Ramipril—type 2 diabetes mellitus	0.000862	0.0012	CcSEcCtD
Propantheline—Vomiting—Ramipril—type 2 diabetes mellitus	0.000829	0.00116	CcSEcCtD
Propantheline—Rash—Ramipril—type 2 diabetes mellitus	0.000822	0.00115	CcSEcCtD
Propantheline—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000821	0.00115	CcSEcCtD
Propantheline—Headache—Ramipril—type 2 diabetes mellitus	0.000817	0.00114	CcSEcCtD
Propantheline—Nausea—Ramipril—type 2 diabetes mellitus	0.000774	0.00108	CcSEcCtD
Propantheline—CHRM3—Metabolism—CYP2E1—type 2 diabetes mellitus	8.88e-05	0.000314	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—INSR—type 2 diabetes mellitus	8.86e-05	0.000313	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	8.84e-05	0.000312	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	8.81e-05	0.000311	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AGT—type 2 diabetes mellitus	8.81e-05	0.000311	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	8.8e-05	0.000311	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TRPC6—type 2 diabetes mellitus	8.79e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP1A2—type 2 diabetes mellitus	8.78e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—SLC2A1—type 2 diabetes mellitus	8.78e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	8.78e-05	0.00031	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	8.76e-05	0.000309	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGTR2—type 2 diabetes mellitus	8.74e-05	0.000308	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AGT—type 2 diabetes mellitus	8.73e-05	0.000308	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	8.7e-05	0.000307	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	8.69e-05	0.000307	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	8.65e-05	0.000305	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	8.64e-05	0.000305	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCR5—type 2 diabetes mellitus	8.62e-05	0.000304	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CYP3A4—type 2 diabetes mellitus	8.57e-05	0.000302	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCR5—type 2 diabetes mellitus	8.53e-05	0.000301	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—C3—type 2 diabetes mellitus	8.45e-05	0.000298	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—C3—type 2 diabetes mellitus	8.42e-05	0.000297	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GCG—type 2 diabetes mellitus	8.42e-05	0.000297	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—SLC2A4—type 2 diabetes mellitus	8.42e-05	0.000297	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.39e-05	0.000296	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.37e-05	0.000295	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—C3—type 2 diabetes mellitus	8.34e-05	0.000294	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.28e-05	0.000292	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	8.17e-05	0.000288	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.15e-05	0.000288	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.15e-05	0.000288	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	8.14e-05	0.000287	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.12e-05	0.000287	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.12e-05	0.000287	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	8.06e-05	0.000285	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.04e-05	0.000284	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.04e-05	0.000284	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AGT—type 2 diabetes mellitus	8.03e-05	0.000283	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AGT—type 2 diabetes mellitus	8e-05	0.000282	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.92e-05	0.00028	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AGT—type 2 diabetes mellitus	7.92e-05	0.00028	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.9e-05	0.000279	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	7.89e-05	0.000279	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.89e-05	0.000279	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CALM1—type 2 diabetes mellitus	7.87e-05	0.000278	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.86e-05	0.000278	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	7.82e-05	0.000276	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CALM1—type 2 diabetes mellitus	7.79e-05	0.000275	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CYBA—type 2 diabetes mellitus	7.79e-05	0.000275	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.76e-05	0.000274	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.73e-05	0.000273	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.72e-05	0.000273	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.72e-05	0.000273	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.7e-05	0.000272	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.7e-05	0.000272	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.66e-05	0.00027	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.63e-05	0.000269	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.62e-05	0.000269	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.62e-05	0.000269	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.6e-05	0.000268	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.53e-05	0.000266	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.42e-05	0.000262	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.39e-05	0.000261	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	7.32e-05	0.000258	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GNB3—type 2 diabetes mellitus	7.26e-05	0.000256	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.26e-05	0.000256	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—HMOX1—type 2 diabetes mellitus	7.22e-05	0.000255	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.18e-05	0.000254	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.16e-05	0.000253	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.15e-05	0.000252	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.13e-05	0.000252	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CAT—type 2 diabetes mellitus	7.13e-05	0.000252	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.09e-05	0.00025	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.06e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GCG—type 2 diabetes mellitus	7.06e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	7.06e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GCG—type 2 diabetes mellitus	7.04e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.04e-05	0.000249	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	6.97e-05	0.000246	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GCG—type 2 diabetes mellitus	6.97e-05	0.000246	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.95e-05	0.000245	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.93e-05	0.000245	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.93e-05	0.000245	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOB—type 2 diabetes mellitus	6.92e-05	0.000244	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.9e-05	0.000244	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	6.86e-05	0.000242	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	6.84e-05	0.000241	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GSTM1—type 2 diabetes mellitus	6.73e-05	0.000238	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.61e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—LPL—type 2 diabetes mellitus	6.61e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.59e-05	0.000233	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—CCL2—type 2 diabetes mellitus	6.53e-05	0.00023	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.49e-05	0.000229	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.49e-05	0.000229	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.47e-05	0.000229	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ADCY5—type 2 diabetes mellitus	6.47e-05	0.000228	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.47e-05	0.000228	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—GPX1—type 2 diabetes mellitus	6.45e-05	0.000228	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT2—type 2 diabetes mellitus	6.41e-05	0.000226	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	6.4e-05	0.000226	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CD36—type 2 diabetes mellitus	6.28e-05	0.000222	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPP2CA—type 2 diabetes mellitus	6.2e-05	0.000219	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.14e-05	0.000217	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.13e-05	0.000216	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.09e-05	0.000215	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.07e-05	0.000214	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.07e-05	0.000214	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.01e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AVP—type 2 diabetes mellitus	6.01e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.01e-05	0.000212	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.99e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AVP—type 2 diabetes mellitus	5.99e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.98e-05	0.000211	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.96e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.95e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—MTHFR—type 2 diabetes mellitus	5.95e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.93e-05	0.00021	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AVP—type 2 diabetes mellitus	5.93e-05	0.000209	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP3—type 2 diabetes mellitus	5.93e-05	0.000209	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF2—type 2 diabetes mellitus	5.9e-05	0.000208	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.89e-05	0.000208	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	5.88e-05	0.000207	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.87e-05	0.000207	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARA—type 2 diabetes mellitus	5.84e-05	0.000206	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	5.82e-05	0.000205	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOB—type 2 diabetes mellitus	5.8e-05	0.000205	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOB—type 2 diabetes mellitus	5.79e-05	0.000204	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.78e-05	0.000204	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.76e-05	0.000203	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOB—type 2 diabetes mellitus	5.73e-05	0.000202	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.71e-05	0.000202	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.71e-05	0.000201	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.69e-05	0.000201	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AGT—type 2 diabetes mellitus	5.65e-05	0.0002	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.64e-05	0.000199	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—CALM1—type 2 diabetes mellitus	5.56e-05	0.000196	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LPL—type 2 diabetes mellitus	5.54e-05	0.000196	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOE—type 2 diabetes mellitus	5.54e-05	0.000196	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LPL—type 2 diabetes mellitus	5.53e-05	0.000195	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—APOA1—type 2 diabetes mellitus	5.48e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.47e-05	0.000193	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.43e-05	0.000192	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.41e-05	0.000191	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.36e-05	0.000189	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.2e-05	0.000184	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.18e-05	0.000183	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.13e-05	0.000181	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.11e-05	0.00018	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.09e-05	0.00018	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.04e-05	0.000178	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—C3—type 2 diabetes mellitus	4.99e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—C3—type 2 diabetes mellitus	4.97e-05	0.000176	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—C3—type 2 diabetes mellitus	4.93e-05	0.000174	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PPARG—type 2 diabetes mellitus	4.82e-05	0.00017	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.76e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.75e-05	0.000168	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.74e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AGT—type 2 diabetes mellitus	4.74e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.73e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—INS—type 2 diabetes mellitus	4.73e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AGT—type 2 diabetes mellitus	4.73e-05	0.000167	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.7e-05	0.000166	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.69e-05	0.000165	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.68e-05	0.000165	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.66e-05	0.000165	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.65e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOE—type 2 diabetes mellitus	4.65e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—LEP—type 2 diabetes mellitus	4.65e-05	0.000164	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOE—type 2 diabetes mellitus	4.63e-05	0.000163	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—LEP—type 2 diabetes mellitus	4.63e-05	0.000163	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.6e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.59e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.59e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.59e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.58e-05	0.000162	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.53e-05	0.00016	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.38e-05	0.000155	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.37e-05	0.000154	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—ALB—type 2 diabetes mellitus	4.34e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.33e-05	0.000153	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PIK3R1—type 2 diabetes mellitus	4.15e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—NOS3—type 2 diabetes mellitus	4.15e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.14e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.13e-05	0.000146	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.09e-05	0.000144	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—INS—type 2 diabetes mellitus	3.97e-05	0.00014	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—INS—type 2 diabetes mellitus	3.96e-05	0.00014	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—INS—type 2 diabetes mellitus	3.92e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.91e-05	0.000138	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.89e-05	0.000137	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.85e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.84e-05	0.000136	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.84e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.83e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.82e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.82e-05	0.000135	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.81e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—PTGS2—type 2 diabetes mellitus	3.8e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.79e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.79e-05	0.000134	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.77e-05	0.000133	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.65e-05	0.000129	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.63e-05	0.000128	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.6e-05	0.000127	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.48e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.48e-05	0.000123	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.47e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.47e-05	0.000122	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.44e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.44e-05	0.000121	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—RELA—type 2 diabetes mellitus	3.28e-05	0.000116	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.27e-05	0.000115	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.23e-05	0.000114	CbGpPWpGaD
Propantheline—CHRM1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.98e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.97e-05	0.000105	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.96e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.95e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.94e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.94e-05	0.000104	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.93e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.92e-05	0.000103	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.9e-05	0.000102	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.79e-05	9.86e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.78e-05	9.83e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.76e-05	9.75e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.76e-05	9.73e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.75e-05	9.72e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.73e-05	9.63e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.71e-05	9.56e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.7e-05	9.53e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.67e-05	9.44e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—SRC—type 2 diabetes mellitus	2.57e-05	9.09e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—SRC—type 2 diabetes mellitus	2.57e-05	9.06e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.54e-05	8.97e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.51e-05	8.85e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.5e-05	8.82e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.48e-05	8.74e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.3e-05	8.13e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.29e-05	8.1e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.27e-05	8.02e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.26e-05	7.97e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.25e-05	7.94e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.23e-05	7.86e-05	CbGpPWpGaD
Propantheline—CHRM3—Metabolism—AKT1—type 2 diabetes mellitus	1.91e-05	6.73e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.73e-05	6.12e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.73e-05	6.1e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.71e-05	6.04e-05	CbGpPWpGaD
Propantheline—CHRM1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.6e-05	5.65e-05	CbGpPWpGaD
Propantheline—CHRM3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.59e-05	5.63e-05	CbGpPWpGaD
Propantheline—CHRM2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.58e-05	5.58e-05	CbGpPWpGaD
